Anhydrous Powder Hair Lightening Suspension
Summary
USPTO published patent application US20260096960A1 by inventor David Erlingheuser for an anhydrous powder hair lightening suspension composition on April 9, 2026. The composition comprises 5-60% non-volatile oil, 3-30% petrolatum, 0.05-5% fumed silica, 1-70% persulfate salt, and 0% microplastics. This publication establishes a priority date and provides public notice of the pending patent claims.
What changed
USPTO published patent application US20260096960A1 for an anhydrous powder hair lightening suspension by inventor David Erlingheuser on April 9, 2026. The application covers a crème composition for lightening keratin fibers containing petrolatum, fumed silica, and persulfate salt with 0% microplastics.
Affected parties including cosmetic manufacturers should monitor for future patent grant notices or office actions that may affect freedom-to-operate assessments for hair lightening products.
What to do next
- Monitor for updates
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Anhydrous Powder Hair Lightening Suspension
Application US20260096960A1 Kind: A1 Apr 09, 2026
Inventors
David Erlingheuser
Abstract
A crème composition for lightening keratin fibers that includes about 5 to about 60% by weight of a non-volatile oil component, about 3 to about 30% by weight petrolatum, about 0.05 to about 5% by weight fumed silica, about 1 to about 70% by weight of a persulfate salt, and 0% by weight microplastics.
CPC Classifications
A61K 8/23 A61K 8/25 A61K 8/31 A61Q 5/08 A61K 2800/30
Filing Date
2025-10-07
Application No.
19352434
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.